Because large studies did not show robust, reproducible weightloss outcomes, development as a formal obesity drug was discontinued, and AOD9604 today is typically used offlabel as a wellness or bodycomposition adjunct rather than an FDAapproved obesity medication
Simply book a consultation with our medical team
Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
Just real medical guidance and custom care that helps you move forward with clarity and confidence
MIC + B12 is not a rapid weight-loss treatment on its own
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy